Global Startup and Venture Investment News for January 31, 2026: Major Funding Rounds, Venture Fund Activity, AI Investments, and Key Technology Trends for Investors
The beginning of 2026 demonstrates the continued upswing in the global startup and venture capital markets. After a year of increasing investments, venture funds and corporations are once again actively investing in promising companies. Major investors are forming record funds while tech startups around the world are closing funding rounds worth hundreds of millions of dollars, despite a more selective approach to projects. Capital remains particularly interested in artificial intelligence (AI), biotechnology, "green" and strategic technologies that have the potential to shape the future of industries and national security. Below is an overview of the key news from the world of startups and venture investments as of January 31, 2026.
Venture Market Riding a Growth Wave After a Successful 2025
The global venture market entered 2026 on a positive note. According to industry analysts, funding for startups significantly increased in 2025 compared to the previous downturn. For example, in North America, startups attracted approximately $280 billion in venture capital last year, which is nearly 46% more than the previous year. The main driver of this growth was the boom in AI projects—the majority of the funding went to AI startups. Venture investors worldwide are once again prepared to invest in innovative companies, especially in breakthrough sectors. The first weeks of 2026 confirm this trend, with several large deals announced and new funds launched, signaling the continued positive momentum in the venture market.
Andreessen Horowitz Raises Record Mega Fund
One of the most notable signals of investor confidence has been the unprecedented new fund from Silicon Valley's Andreessen Horowitz (a16z). The company announced that it has raised over $15 billion for several new venture funds across various domains—a record amount not only for a16z but also one of the largest in the history of the venture capital market. The funds are divided among several pools: approximately $6.75 billion is allocated for late "growth" stage investments, around $1.2 billion is directed to the specialized fund American Dynamism (focused on startups in national security and defense), along with separate funds of approximately $1.7 billion for investments in applied technologies and infrastructure projects, and $700 million for biotech and healthcare, among other verticals. Andreessen Horowitz management emphasizes a strategic focus on technologies that reinforce U.S. technological leadership—from artificial intelligence and cryptocurrency to defense, education, and biomedicine. Industry estimates suggest that a16z now manages approximately 18% of all venture investments made in the U.S. last year. The emergence of this new mega fund amid 2025 being the quietest year for fundraising since 2017 signals a return of confidence: investors are prepared to entrust record sums to proven players in search of the "next big ideas" among startups.
AI Investment Boom Continues
The artificial intelligence sector remains the primary magnet for venture capital in 2026. Following last year's excitement, interest in AI startups shows no signs of waning: in the early weeks of the new year, several massive deals have already been recorded, even at early stages. Last week, the startup lab Humans&, founded by a team of leading researchers from Google, OpenAI, Anthropic, and Meta, attracted approximately $480 million in seed funding—an unprecedented amount for such an early stage. Another example is Ricursive Intelligence, an ambitious advanced AI project that announced a $300 million Series A round with a valuation of roughly $4 billion. Projects led by well-known entrepreneurs are also capturing attention: the new startup Merge Labs, founded by OpenAI co-founder Sam Altman and developing brain-computer interfaces integrated with AI, reportedly secured around $252 million in initial funding. Altogether, according to Crunchbase, over 40% of all investments at the seed and Series A stages in 2026 have already been allocated to rounds of $100 million or more—a previously rare occurrence made possible largely due to the AI race. Venture investors still view artificial intelligence as a key growth area and are willing to compete for the most promising teams. The competition for talent and cutting-edge developments in AI remains high, with startups continuing to secure large checks for scaling solutions in the realms of generative AI, voice and visual algorithms, business process automation, and other areas.
New "Unicorns" in Defense Technologies and Artificial Intelligence
A series of significant early-year deals has added to the ranks of "unicorns"—private companies valued at over $1 billion. Several startups have achieved this status through funding rounds:
- Deepgram (U.S., voice AI)—raised $130 million in a Series C round at a valuation of about $1.3 billion, becoming one of the leaders in the AI voice technology segment.
- Harmattan AI (France, AI-based defense systems)—secured approximately $200 million in a Series B round, boosting the Paris-based startup's valuation to $1.4 billion. Harmattan AI has become a rare "unicorn" in a strategically important area of defense technology for Europe.
- Defense Unicorns (U.S., secure software for government agencies)—closed a $136 million Series B round led by Bain Capital, achieving a valuation of over $1 billion. The company has justified its name by joining the unicorn club amid rapid revenue growth from Pentagon contracts.
The emergence of these newly highly valued players reflects the increasing focus of venture capital on projects related to artificial intelligence and national security. In line with the trend set by funds like a16z American Dynamism, investors are actively financing companies engaged in both commercial AI products (such as voice assistants for business) and government-relevant technologies (defense, cybersecurity). The venture race is global in nature: the formation of new unicorns involves not only Silicon Valley but also Europe, Asia, and other regions where tech companies with billion-dollar valuations are emerging.
Tech Giants Hunting for AI Startups
Not only venture funds but also major corporations are striving to enhance their positions in the field of artificial intelligence. A notable example is Apple, which has executed one of its largest deals in recent years by agreeing to acquire the Israeli AI startup Q.ai, specializing in AI-based audio technologies. According to insiders, the acquisition cost was around $1.6 billion, making this purchase Apple's second-largest ever (after the acquisition of Beats). The startup Q.ai develops machine learning systems for whisper speech recognition and sound enhancement in difficult conditions, and its team of approximately 100 specialists will join Apple. The deal highlights the intensity of competition among Big Tech for breakthrough AI developments: companies such as Apple, Google, Microsoft, and Meta are actively acquiring promising projects to avoid falling behind in the AI technology race. For startups and their investors, such exits are validating high valuations: large strategic players are willing to pay billions for access to advanced solutions and talent in the AI sector.
Multi-Million Dollar Rounds in Biotech Signal Revival
The biotechnology sector is also keeping pace: in January, several biotech startups announced major funding rounds, indicating a resurgence of investor interest in healthcare. The most notable deal is the $305 million Series F round for Parabilis Medicines from Massachusetts (formerly known as FogPharma). The capital raised will enable Parabilis to advance its experimental anti-cancer drug (the peptide zolucatetide) into the crucial phase of clinical trials and expand its platform technologies for peptide cell penetration to develop new drugs. Notably, Parabilis has attracted venture funding six times already, remaining a private company longer than is typical for the industry. Such a large late round from well-known investors (including public market funds) speaks to the high confidence in the prospects of its scientific developments.
Another noteworthy case is the California startup Soley Therapeutics, which raised approximately $200 million in a Series C round. The company is applying artificial intelligence and computational biology technologies to discover new cancer treatments and will direct the raised funds towards advancing two of its candidates to clinical trial stages. Records are also occurring at earlier stages: a very young biotech company AirNexis Therapeutics received $200 million in seed funding (Series A) for developing an innovative drug for lung diseases. Such a level of investment at the A stage is rare, indicating high confidence in the project's developments: AirNexis has licensed a promising molecule from the Chinese pharmaceutical company Haisco and plans to bring it to the global market for treating COPD (asthma and chronic obstructive pulmonary disease).
In addition to these mega-rounds, there has been a series of more moderate deals: industry observers recorded at least half a dozen biotech startups attracting between $50 million and $100 million each during January. All this points to a new revival in biotech after the challenging years of recent history: venture funds are once again actively financing companies in pharmaceuticals and medicine, especially if the startup has breakthrough science or a market-ready product. Major crossover investors (funds operating in both private and public markets) are returning to biotech, laying the groundwork for renewed IPOs if market conditions allow.
New Specialized Venture Funds Emerging Globally
In addition to funding startups themselves, capital is actively flowing into the ecosystem through new venture funds that are often focused on narrow niches or strategic themes. The startup industry is diversifying, as evidenced by the emergence of specialized funds in various regions at the beginning of 2026. Here are a few notable examples:
- All Aboard Alliance (Global) – a coalition of private venture firms (including Bill Gates' Breakthrough Energy Ventures) has announced the establishment of a $300 million fund to invest in startups linked to climate change and greenhouse gas reduction. Initial investments are expected within the year, reflecting the growing interest in climate tech.
- 2150 VC (Europe) – the London-Copenhagen venture fund 2150 closed a second fund of €210 million, raising total assets under management to €500 million. The funds will support startups developing sustainable urban technologies (urban climate solutions, green building, and infrastructure projects).
- VZVC (U.S.) – a new venture firm founded by former a16z partner Vijaj Pandey is forming a debut fund estimated at $400 million for investments at the intersection of artificial intelligence and digital health. This example illustrates a trend where experienced investors leave large funds to focus on rapidly growing niche areas.
- NUS Venture Fund (Asia) – the National University of Singapore has launched a venture fund of $120 million to support its own spin-off startups and university research. This public-private initiative aims to commercialize academic innovations and strengthen the local startup ecosystem.
Alongside the examples mentioned, corporate and regional development funds continue to emerge. Large corporations and governments are increasingly participating in the venture ecosystem by creating funds to support priority sectors—from climate technologies and biomedicine to defense and artificial intelligence. As a result, the landscape of venture capital is becoming more diverse: alongside billion-dollar mega-funds, compact targeted funds coexist. For startups, this means more opportunities to secure funding globally, including in segments that were recently considered exotic for venture capital.
Expectations and Outlook: IPOs and Further Market Growth
Such an active start to the year creates cautious optimism among venture market players regarding forecasts for 2026. On the one hand, record funding rounds and the emergence of new funds provide startups with access to capital. On the other hand, investors will be more vigilant about tracking the effectiveness of investments and the development of portfolio companies. A key indicator of sentiment may be the revival of companies entering the stock market. Following a lull in recent years with only a few notable tech IPOs in 2025, a queue of unicorns expected to try their luck on the public market is anticipated for 2026, provided market conditions improve.
Venture funds are already preparing potential IPO candidates. There are rumors of several large AI and fintech companies from Silicon Valley planning to go public, as well as some biotech firms that have successfully attracted crossover investors at late stages. Among the most awaited in the industry are potential IPOs of giants like OpenAI, Anthropic, or even the space company SpaceX—such listings could invigorate the market and attract widespread public attention. High valuations that startups have obtained in recent rounds suggest an expectation of imminent exits—either through sale to a strategic investor or via public offerings.
Meanwhile, the volume of available "dry powder"—meaning uninvested funds in venture capital—is still substantial. According to PitchBook, impact investment funds currently control over $200 billion in unutilized capital, while the overall global venture dry powder is measured in several hundreds of billions of dollars. These capital reserves have the potential to sustain high financing rates for innovations even with shifts in economic conditions, creating competition for prime deals.
Certainly, certain risks remain: rising interest rates, geopolitical instability, and stock market volatility could temper investors' appetite for risk. Nonetheless, at this moment, the startup ecosystem enters the new year with a strong buffer and restrained optimism. Venture investors and company founders hope that 2026 will be a period of further growth—provided that project assessments are reasonable and the macroeconomic climate is favorable.
